Oric Pharmaceuticals, Inc.·4

Jun 24, 6:33 PM ET

Piscitelli Dominic 4

4 · Oric Pharmaceuticals, Inc. · Filed Jun 24, 2025

Insider Transaction Report

Form 4
Period: 2025-06-23
Piscitelli Dominic
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2025-06-24$10.50/sh32,466$341,03968,317 total
  • Sale

    Common Stock

    2025-06-23$10.00/sh584$5,840101,233 total
  • Sale

    Common Stock

    2025-06-23$10.01/sh450$4,505100,783 total
Footnotes (2)
  • [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2024.
  • [F2]Represents the weighted average share price of an aggregate total of 32,466 shares sold in the price range of $10.34 to $10.80 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Documents

1 file
  • 4
    form4-06242025_100608.xmlPrimary